Kalvista Pharmaceuticals Inc (KALV)
Operating Income Growth
25.52%
TTM · Period ending:
KALV Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported25.52%period ending
Latest reported25.52%period ending
KALV TTM Operating Income YoY % (-115.56% → 25.52%)
Year-over-year change
High-resolution chart · PNG
KALV operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 25.5237% | |
| -1.163% | |
| -18.2932% | |
| -30.3554% | |
| -33.8574% | |
| -46.6407% | |
| -46.0549% | |
| -36.8837% | |
| -26.6731% | |
| -16.7647% | |
| -11.1824% | |
| -9.8982% | |
| -14.7589% | |
| -20.6172% | |
| -43.1805% | |
| -64.158% | |
| -66.7956% | |
| -79.8681% | |
| -50.9416% | |
| -38.718% | |
| -42.8998% | |
| -14.0089% | |
| -32.9916% | |
| -40.2631% | |
| -35.9198% | |
| -98.955% | |
| -91.3566% | |
| -59.7996% | |
| -59.4333% | |
| -3.4051% | |
| 21.8599% | |
| 3.7985% | |
| -3.8417% | |
| -7.0265% | |
| -45.4605% | |
| -8.5563% | |
| 20.518% | |
| 7.5157% | |
| 12.3263% | |
| -8.0655% | |
| -53.9397% | |
| -80.149% | |
| -115.56% |